ZOTA HEALTH CARE
|
ZOTA HEALTH CARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -19.70 | -5.55 | -2.29 | 3.54 | -0.09 |
| CEPS(Rs) | -4.73 | 2.22 | 2.46 | 5.00 | 1.21 |
| DPS(Rs) | 1.00 | 1.00 | 1.00 | 1.50 | 1.00 |
| Book NAV/Share(Rs) | 78.12 | 34.81 | 31.94 | 35.62 | 26.99 |
| Tax Rate(%) | 1.57 | 11.23 | -23.06 | 28.37 | 42.83 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -2.08 | 4.19 | 4.76 | 11.00 | 0.54 |
| EBIT Margin(%) | -15.99 | -6.30 | -1.52 | 9.72 | -0.24 |
| Pre Tax Margin(%) | -19.68 | -8.96 | -3.35 | 9.48 | -0.34 |
| PAT Margin (%) | -19.37 | -7.95 | -4.12 | 6.79 | -0.20 |
| Cash Profit Margin (%) | -4.62 | 3.18 | 4.42 | 9.59 | 2.77 |
| Performance Ratios | |||||
| ROA(%) | -17.34 | -7.53 | -3.90 | 7.94 | -0.24 |
| ROE(%) | -36.18 | -16.85 | -6.79 | 11.43 | -0.31 |
| ROCE(%) | -28.07 | -12.30 | -2.50 | 16.36 | -0.38 |
| Asset Turnover(x) | 0.90 | 0.95 | 0.95 | 1.17 | 1.23 |
| Sales/Fixed Asset(x) | 1.45 | 1.56 | 2.10 | 3.37 | 3.68 |
| Working Capital/Sales(x) | 3.51 | 4.76 | 3.21 | 3.20 | 2.48 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.69 | 0.64 | 0.48 | 0.30 | 0.27 |
| Receivable days | 42.20 | 55.69 | 83.71 | 90.61 | 98.96 |
| Inventory Days | 99.32 | 96.62 | 92.24 | 79.46 | 91.46 |
| Payable days | 101.03 | 113.36 | 98.97 | 72.26 | 76.17 |
| Valuation Parameters | |||||
| PER(x) | - | - | - | 84.06 | - |
| PCE(x) | -170.28 | 213.77 | 114.63 | 59.53 | 114.93 |
| Price/Book(x) | 10.31 | 13.63 | 8.82 | 8.35 | 5.13 |
| Yield(%) | 0.12 | 0.21 | 0.35 | 0.50 | 0.72 |
| EV/Net Sales(x) | 7.89 | 6.87 | 5.06 | 5.69 | 3.17 |
| EV/Core EBITDA(x) | -629.80 | 142.37 | 76.18 | 45.44 | 179.81 |
| EV/EBIT(x) | -49.25 | -109.02 | -332.68 | 58.52 | -1,325.56 |
| EV/CE(x) | 10.07 | 11.85 | 8.81 | 5.37 | 3.96 |
| M Cap / Sales | 7.88 | 6.80 | 5.07 | 5.71 | 3.19 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 62.21 | 28.96 | 6.67 | 22.86 | 12.25 |
| Core EBITDA Growth(%) | -142.07 | -6.25 | -43.44 | 771.77 | -68.74 |
| EBIT Growth(%) | -311.97 | -434.65 | -116.68 | 5,090.41 | -106.50 |
| PAT Growth(%) | -295.45 | -148.54 | -164.81 | 4,364.05 | -107.62 |
| EPS Growth(%) | -254.81 | -141.94 | -164.81 | 4,262.36 | -107.62 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.03 | 0.16 | - | - | - |
| Current Ratio(x) | 1.83 | 1.51 | 2.08 | 2.14 | 3.36 |
| Quick Ratio(x) | 0.78 | 0.79 | 1.05 | 1.33 | 1.81 |
| Interest Cover(x) | -4.35 | -2.38 | -0.83 | 39.77 | -2.33 |
| Total Debt/Mcap(x) | - | 0.01 | - | - | - |
Compare Financial Ratios of peers of ZOTA HEALTH CARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZOTA HEALTH CARE | ₹4,638.8 Cr | -3.8% | 7.4% | 159.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
ZOTA HEALTH CARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZOTA HEALTH CARE | -3.8% |
7.4% |
159.5% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses
